Advertisement

Wound Healing in Hidradenitis Suppurativa

  • Asma Asif Amir Ali
  • Michelle A. Lowes
  • Afsaneh Alavi
Chapter
  • 115 Downloads
Part of the Updates in Clinical Dermatology book series (UCD)

Abstract

Hidradenitis suppurativa (HS) is a chronic, debilitating disease that is challenging to treat. It presents with recurrent nodules and tunnels that often drain. The exudate, pain, and odor associated with these lesions can impose a significant psychosocial burden on patients. As a result, optimal wound care is an important adjunct to the medical and/or surgical therapy for these patients. The wound care framework for patients with HS is similar to general wound care. The algorithm employed for HS wound care starts with first classifying wounds as post-surgical or non-surgical. For post-surgical wounds, it is important to determine whether the wound is simple or complex, whereas for non-surgical wounds, determining the amount of exudate and the presence of infection is essential in choosing the ideal dressing. Ultimately, it is of utmost importance to educate the patient on the kind of wound care their disease necessitates and to understand what barriers a patient may face in adhering to optimal wound care.

Keywords

Hidradenitis suppurativa Wound care Biofilms Hurley stage Foam dressings Gelling fibers Calcium alginate Non-adherent dressings Gel-based dressings Dressings with antiseptics Negative pressure wound therapies Cellular skin substitutes Acellular skin substitutes 

Abbreviations

HS

Hidradenitis suppurativa

I&D

Incision and drainage

NPWT

Negative pressure wound therapy

PHMB

Polyhexamethylene biguanide

PRP

Platelet-rich plasma

Notes

Conflict of Interest

  • AA has consulted for AbbVie, Janssen, LEO, Galderma, Novartis, and Valeant and is also an investigator for AbbVie, Novartis, Regeneron, Pfizer, Boehringer-Ingelheim, Glenmark, Merck Serono, Roche, Xoma, and Xenon. AA received an unrestricted educational grant from AbbVie.

  • MAL has consulted for AbbVie, Incyte, Janssen, BSN, and Xbiotech.

  • All authors state no conflict related to this manuscript.

References

  1. 1.
    Revuz J. Hidradenitis suppurativa. Presse Med. 2010;39(12):1254–64.CrossRefGoogle Scholar
  2. 2.
    Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546–9.CrossRefGoogle Scholar
  3. 3.
    Hoffman LK, Ghias MH, Lowes MA. Pathophysiology of hidradenitis suppurativa. Semin Cutan Med Surg. 2017;36(2):47–54.CrossRefGoogle Scholar
  4. 4.
    Nikolakis G, Liakou AI, Bonovas S, Seltmann H, Bonitsis N, Join-Lambert O, et al. Bacterial colonization in hidradenitis suppurativa/acne inversa: a cross-sectional study of 50 patients and review of the literature. Acta Derm Venereol. 2017;97(4):493–8.CrossRefGoogle Scholar
  5. 5.
    Ring HC, Bay L, Nilsson M, Kallenbach K, Miller IM, Saunte DM, et al. Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol. 2017;176(4):993–1000.CrossRefGoogle Scholar
  6. 6.
    Kathju S, Lasko L-A, Stoodley P. Considering hidradenitis suppurativa as a bacterial biofilm disease. FEMS Immunol Med Microbiol. 2012;65(2):385–9.CrossRefGoogle Scholar
  7. 7.
    Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91(3):328–32.CrossRefGoogle Scholar
  8. 8.
    Patel ZS, Hoffman LK, Buse DC, Grinberg AS, Afifi L, Cohen SR, et al. Pain, psychological comorbidities, disability, and impaired qualify of life in hidradenitis suppurativa. Curr Pain Headache Rep. 2017;21(12):49.CrossRefGoogle Scholar
  9. 9.
    van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475–80.CrossRefGoogle Scholar
  10. 10.
    Scuderi N, Monfrecola A, Dessy LA, Fabbrocini G, Megna M, Monfrecola G. Medical and surgical treatment of hidradenitis suppurativa: a review. Skin Appendage Disorders. 2017;3(2):95–110.CrossRefGoogle Scholar
  11. 11.
    Vellaichamy G, Braunberger TL, Nahhas AF, Hamzavi IH. Surgical procedures for hidradenitis suppurativa. Cutis. 2018;102(1):13–6.PubMedGoogle Scholar
  12. 12.
    Sibbald RG, Goodman L, Woo KY, Krasner DL, Smart H, Tariq G, et al. Special considerations in wound bed preparation 2011: an update(c). Adv Skin Wound Care. 2011;24(9):415–36; quiz 37–8.CrossRefGoogle Scholar
  13. 13.
    Nelson A. Extracellular traps and matrix metalloproteases are components of the invasive proliferative gelatinous mass in hidradenitis suppurativa. Symposium on Hidradenitis Suppurativa Advances; October 13, 2018; Toronto; 2018.Google Scholar
  14. 14.
    Antia C, Alavi A, Alikhan A. Topical management and wound care approaches for hidradenitis suppurativa. Semin Cutan Med Surg. 2017;36(2):58–61.CrossRefGoogle Scholar
  15. 15.
    Naik HB, Nassif A, Ramesh M, Schultz G, Piguet V, Alavi A, et al. Are bacteria infectious pathogens in hidradenitis suppurativa (HS)?. J Invest Dermatol. 2019;139(1):13–6.Google Scholar
  16. 16.
    Alavi A, Sibbald RG, Kirsner RS. Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatolog Treat. 2018;29(4):383–4.CrossRefGoogle Scholar
  17. 17.
    Kazemi A, Carnaggio K, Clark M, Shephard C, Okoye GA. Optimal wound care management in hidradenitis suppurativa. J Dermatolog Treat. 2018;29(2):165–7.CrossRefGoogle Scholar
  18. 18.
    Bredow J, Oppermann J, Hoffmann K, Hellmich M, Wenk B, Simons M, et al. Clinical trial to evaluate the performance of a flexible self-adherent absorbent dressing coated with a soft silicone layer compared to a standard wound dressing after orthopedic or spinal surgery: study protocol for a randomized controlled trial. Trials. 2015;16(1):81.CrossRefGoogle Scholar
  19. 19.
    Stéphane P, Maxime C, Alexandre D, Jolène P. Reduction of tape blisters after hip surgery – a prospective evaluation of three kinds of bandages. Orthop Proceed. 2012;94-B(SUPP_XXXVIII):164.Google Scholar
  20. 20.
    Barnea Y, Weiss J, Gur E. A review of the applications of the hydrofiber dressing with silver (Aquacel Ag(®)) in wound care. Ther Clin Risk Manag. 2010;6:21–7.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Vassallo IM, Formosa C. Comparing calcium alginate dressings to vacuum-assisted closure: a clinical trial. Wounds. 2015;27(7):180–90.PubMedGoogle Scholar
  22. 22.
    Skorkowska-Telichowska K, Czemplik M, Kulma A, Szopa J. The local treatment and available dressings designed for chronic wounds. J Am Acad Dermatol. 2013;68(4):e117–e26.CrossRefGoogle Scholar
  23. 23.
    Jones V, Grey JE, Harding KG. Wound dressings. BMJ. 2006;332(7544):777–80.CrossRefGoogle Scholar
  24. 24.
    Pandey RK, Jalde DD, Godhi SA, Godhi AS. A randomized control trial to assess the efficacy of calcium alginate dressing versus conventional gauze dressing on bacterial load in infected diabetic foot ulcer. 2011. 126–130 p.Google Scholar
  25. 25.
    Kamoun EA, Kenawy ERS, Chen X. A review on polymeric hydrogel membranes for wound dressing applications: PVA-based hydrogel dressings. J Adv Res. 2017;8(3):217–33.CrossRefGoogle Scholar
  26. 26.
    Rodriguez-Arguello J, Lienhard K, Patel P, Geransar R, Somayaji R, Parsons L, et al. A scoping review of the use of silver-impregnated dressings for the treatment of chronic wounds. Ostomy Wound Manage. 2018;64(3):14–31.CrossRefGoogle Scholar
  27. 27.
    Elwood ET, Bolitho DG. Negative-pressure dressings in the treatment of hidradenitis suppurativa. Ann Plast Surg. 2001;46(1):49–51.CrossRefGoogle Scholar
  28. 28.
    Chen E, Friedman HI. Management of regional hidradenitis suppurativa with vacuum-assisted closure and split thickness skin grafts. Ann Plast Surg. 2011;67(4):397–401.CrossRefGoogle Scholar
  29. 29.
    Vossen AR, van der Zee HH, Prens EP. Accelerated wound healing after wide excisions in Hidradenitis Suppurativa using autologous split-thickness skin grafting and platelet-rich plasma. Int Wound J. 2017;14(3):583–6.CrossRefGoogle Scholar
  30. 30.
    Nicoli F, Balzani A, Lazzeri D, Gentile P, Chilgar RM, Di Pasquali C, et al. Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix. Int Wound J. 2015;12(3):338–43.CrossRefGoogle Scholar
  31. 31.
    Vig K, Chaudhari A, Tripathi S, Dixit S, Sahu R, Pillai S, et al. Advances in skin regeneration using tissue engineering. Int J Mol Sci. 2017;18(4).Google Scholar
  32. 32.
    Melkun ET, Few JW. The use of biosynthetic skin substitute (Biobrane) for axillary reconstruction after surgical excision for hidradenitis suppurativa. Plast Reconstr Surg. 2005;115(5):1385–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Asma Asif Amir Ali
    • 1
  • Michelle A. Lowes
    • 2
  • Afsaneh Alavi
    • 3
  1. 1.Department of DermatologyUniversity of CalgaryCalgaryCanada
  2. 2.The Rockefeller UniversityNew YorkUSA
  3. 3.Division of Dermatology, Department of MedicineWomen’s College Hospital, University of TorontoTorontoCanada

Personalised recommendations